- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI signs Japan cyclotron export deal
Cyclotron developer CTI of Knoxville, TN, has signed an agreementwith Japan Steel Works for sales of CTI cyclotrons in Japan. JapanSteel Works will import CTI's Radioisotope Delivery System (RDS)111 into Japan and will also provide service for the
Cyclotron developer CTI of Knoxville, TN, has signed an agreementwith Japan Steel Works for sales of CTI cyclotrons in Japan. JapanSteel Works will import CTI's Radioisotope Delivery System (RDS)111 into Japan and will also provide service for the devices.
RDS 111 is a self-shielding cyclotron, with relatively lowweight and compact size, compared with other cyclotrons. CTI reducedthe weight of the system by 50%, to a total weight of 42.5 tons.
Japan Steel Works will sell RDS 111 for ¥200 million to¥400 million ($1.85 million to $3.7 million) depending onoptions, and the company hopes to sell two to three a year, accordingto Nikkei English News.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
